Cargando…

Monkeypox treatment: Is tecovirimat the answer?

Detalles Bibliográficos
Autores principales:	Niaz, Faizan, Tariq, Samiuddin, Ali, Syed Mukareem, Memon, Rimsha, Nashwan, Abdulqadir J., Ullah, Irfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573899/ https://www.ncbi.nlm.nih.gov/pubmed/36274371 http://dx.doi.org/10.1016/j.jiph.2022.10.012

Ejemplares similares

Pakistan at the precipice: The looming threat of measles amidst the COVID-19 pandemic
por: Tariq, Samiuddin, et al.
Publicado: (2022)

Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022)

Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023)

Managing and treating Sydenham chorea: A systematic review
por: Tariq, Samiuddin, et al.
Publicado: (2023)

Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
por: Mondi, Annalisa, et al.
Publicado: (2023)

Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
por: Chen, Zhang-Ren, et al.
Publicado: (2022)

Monkeypox: Is it the new pandemic?
por: Sawal, Imaduddin, et al.
Publicado: (2022)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Monkeypox Proctitis: A Case of Targeted Treatment With Tecovirimat
por: Patel, Premalkumar, et al.
Publicado: (2023)

Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat
por: Hernandez, Loren E, et al.
Publicado: (2022)

Tecovirimat for Monkeypox in the Central African Republic under Expanded Access
por: Mbrenga, Festus, et al.
Publicado: (2022)

Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak
por: Perzia, Brittany, et al.
Publicado: (2022)

Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
por: Matias, Wilfredo R, et al.
Publicado: (2022)

Monkeypox infection and resolution after treatment with tecovirimat in two patients with HIV disease
por: Beatty, Norman L., et al.
Publicado: (2022)

In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat
por: Nunes, Desiree dos Santos, et al.
Publicado: (2023)

Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge()()
por: Russo, Andrew T., et al.
Publicado: (2020)

Crimean–Congo hemorrhagic fever epidemic during COVID‐19 in Iraq: A “double whammy”?
por: Shaikh, Omer A., et al.
Publicado: (2022)

Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques
por: Russo, Andrew T, et al.
Publicado: (2018)

A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
por: Almehmadi, Mazen, et al.
Publicado: (2022)

Tecovirimat use among patients with monkeypox (mpox) in Alameda County, California, June–October 2022
por: Ouyang, Megan, et al.
Publicado: (2023)

Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects
por: Das, Tuyelee, et al.
Publicado: (2023)

Tecovirimat for the treatment of severe Mpox in Germany
por: Hermanussen, Lennart, et al.
Publicado: (2023)

Treatments for Monkeypox
por: Sookaromdee, P., et al.
Publicado: (2023)

Enhancing oncology nursing care planning for patients with cancer through Harnessing large language models
por: Nashwan, Abdulqadir J., et al.
Publicado: (2023)

Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus
por: Ali, Yasir, et al.
Publicado: (2023)

The resurgence of polio: The effect of the Covid-19 pandemic on polio eradication
por: Niaz, F., et al.
Publicado: (2023)

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022
por: O’Laughlin, Kevin, et al.
Publicado: (2022)

A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome
por: Viguier, Clément, et al.
Publicado: (2022)

The poliovirus re-emergence: did concentrated efforts against COVID-19 open the door?
por: Shaheen, Nour, et al.
Publicado: (2023)

Langya virus outbreak in China, 2022: Are we on the verge of a new pandemic?
por: Tabassum, Shehroze, et al.
Publicado: (2022)

Monkeypox: Key questions answered
por: Le Page, Michael
Publicado: (2022)

Highly accurate protein structure prediction and drug screen of monkeypox virus proteome
por: Yang, Qiangzhen, et al.
Publicado: (2023)

Monkeypox: is it the time for autopsy?
por: Dafallah, Mumen Abdalazim
Publicado: (2022)

Monkeypox and pregnancy: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Monkeypox and pregnancy: correspondence
por: Schwartz, David A., et al.
Publicado: (2023)

Red herrings in monkeypox
por: Bongiovanni, Marco, et al.
Publicado: (2023)

Monkeypox infection: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Predicting monkeypox incidence: Fear is not over!
por: Khan, Muhammad Imran, et al.
Publicado: (2023)

Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination
por: Raccagni, Angelo Roberto, et al.
Publicado: (2022)

Global Monkeypox Virus Outbreak 2022: A Bibliometric Analysis
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tdvp4b09hv39nq91bvfhk613va